Aspirin in Polycythemia Vera and Essential Thrombocythemia: Current Facts and Perspectives

References

• Berlin N. I. Diagnosis and classification of the polycythemias. Semin. Hematol. 1975; 12: 339–351
   PubMed Web of Science ®Google Scholar
• Berk P. D., Goldberg J. D., Donovan P. B., Fruchtman S. M., Berlin N. I., Wasserman L. R. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Semin. Hematol. 1986; 23: 132–143
   PubMed Web of Science ®Google Scholar
• Pearson T. C., Guthrie D. L., Simpson J., Chinn S., Barosi G., Ferrant A., Lewis S. M., Najean Y. Interpretation of measured red cell mass and plasma volumes in adults. Br. J. Haematol. 1995; 89: 748–756
   PubMed Web of Science ®Google Scholar
• Du Bois D., Du Bois E. F. Clinical calorimetry. A formula to estimate the approximate surface area if height and weight be known. Arch. Intern. Med. 1916; 17: 683
   Google Scholar
• Moore-Gillon J. C., Treacher D. F., Gaminara E. J., Pearson T. C., Cameron I. C. Intermittent hypoxia in patients with unexplained polycythaemia. BMJ 1986; 293: 588–590
   PubMed Web of Science ®Google Scholar
• Westin J., Lanner L.-O., Larsson A., Weinfeld A. Spleen size in polycythaemia. Acta. Med. Scand. 1972; 191: 263–271
   PubMed Web of Science ®Google Scholar
• Bateman S., Lewis S. M., Nicholas A., Zaafran A. Splenic red cell pooling: a diagnostic feature in polycythaemia. Br. J. Haematol. 1978; 40: 389–396
   PubMed Web of Science ®Google Scholar
• Messinezy M., Chapman R., Dudley J. M., Nunan T. O., Pearson T. C. Use of splenic volume estimation to distinguish primary thrombocythaemia from reactive thrombocytosis. Eur. J. Haematol. 1988; 40: 339–342
   PubMed Web of Science ®Google Scholar
• Revesz P., Carneskog J., Wadenvik H., Jarnebarn L., Kutti J. Measurement of spleen size using gamma camera scintigraphy in essential thrombocythaemia. Eur. J. Haematol 1993; 51: 141–143
   PubMed Web of Science ®Google Scholar
• Rasmussen S. N., Christensen B. E., Holm H. H., Kardel T., Stigsby B., Larsen M. Spleen volume determination by ultrasonic scanning. Scand. J. Haematol. 1973; 10: 298–304
   PubMedGoogle Scholar
• Zhang B., Lewis S. M. A study of the reliability of clinical palpation of the spleen. Clin. Lab. Haematol. 1989; 11: 7–10
   PubMedGoogle Scholar
• Messinezy M., Sawyer B., Westwood N. B., Pearson T. C. Idiopathic erythrocytosis—additional new study techniques suggest a heterogenous group. Eur. J. Haematol. 1994; 53: 163–167
   PubMed Web of Science ®Google Scholar
• Rege-Cambrin G., Mecucci C., Tricot G., Michaux J., Louwagie A., Van Hove W., Francart H., Van den Berghe H. A chromosomal profile of polycythemia vera. Cancer Genet. Cytogenet. 1987; 25: 233–245
   PubMed Web of Science ®Google Scholar
• Diez Martin J. L., Graham D. L., Petitt R. M., Dewald G. W. Chromosome studies in 104 patients with polycythemia vera. Mayo. Clin. Proc. 1991; 66: 287–299
   PubMed Web of Science ®Google Scholar
• Swolin B., Weinfeld A., Westin J. A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course. Blood 1988; 72: 386–395
   PubMed Web of Science ®Google Scholar
• Wolstenholme J. An introduction to human chromosomes and their analysis. Human cytogenetics. A practical approach. Vol 1. Constitutional analysis. 2nd Edn., D. E. Rooney, B. H. Czepulkowski. Oxford University Press, Oxford 1992; 1–30
   Google Scholar
• McTaylor K. D., Shetta M., Talpaz M., Kantajian H. M., Hadikar S., Chinault A. C., McCredie K. B., Spitzer G. Myeloproliferative disorders: usefulness of X-linked probes in diagnosis. Leukemia 1989; 3: 419–422
   PubMed Web of Science ®Google Scholar
• Anger B., Janssen J. W. G., Schrezenmeier H., Hehlmann R., Heimpel H., Bartram C. R. Clonal analysis of chronic myeloproliferative disorders using x-linked DNA polymorphisms. Leukemia 1990; 4: 258–261
   PubMed Web of Science ®Google Scholar
• Gale R. E., Wainscoat J. S. Clonal analysis using X-linked DNA polymorphisms. Br. J. Haematol. 1993; 85: 2–8
   PubMed Web of Science ®Google Scholar
• Tsukamoto N., Morita K., Maehara T., Okamoto K., Sakai H., Karasawa M., Naruse T., Omine M. Clonality in chronic myeloproliferative disorders defined by X-chromosome linked probes: demonstration of heterogeneity in lineage involvement. Br. J. Haematol. 1994; 86: 253–258
   PubMed Web of Science ®Google Scholar
• Gale R. E., Wheadon H., Linch D. C. X-chromosome inactivation patterns using HPRT and PGK polymorphisms in haematologically normal and post-chemotherapy females. Br. J. Haematol. 1991; 79: 193–197
   PubMed Web of Science ®Google Scholar
• Gale R. E., Wheadon H., Boulos P., Linch D. C. Tissue specificity of X-chromosome inactivation patterns. Blood 1994; 83: 2899–2905
   PubMed Web of Science ®Google Scholar
• Gale R. E., Wheadon H., Boulos P., Linch D. C. Tissue specificity of X-chromosome inactivation patterns. Br. J. Haematol. 1993; 84(Suppl 1)59
   Google Scholar
• Eaves C. J., Eaves A. C. Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera. Blood 1978; 52: 1196–1210
   PubMed Web of Science ®Google Scholar
• Casadevall N., Vainchenker W., Lacombe C., Vinci G., Chapman J., Breton-Gorius J., Varet B. Erythroid progenitors in polycythemia vera: demonstration of their hypersensitivity to erythropoietin using serum free cultures. Blood 1982; 59: 447–451
   PubMed Web of Science ®Google Scholar
• Dai C. H., Krantz S. B., Means R. T., Horn S. T., Gilbert H. S. Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3. J. Clin. Invest. 1991; 87: 391–396
   PubMed Web of Science ®Google Scholar
• Dai C. H., Krantz S. B., Dessypris E. N., Means R. T., Horn S. T., Gilbert H. S. Polycythaemia vera II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte macrophage colony-stimulating factor. Blood 1992; 80: 891–899
   PubMed Web of Science ®Google Scholar
• Dai C. H., Krantz S. B., Green W. F., Gilbert H. S. Polycythemia vera III. Burst-forming units-erythroid (BFU-E) response to stem cell factor and c-kit receptor expression. Br. J. Haematol. 1994; 86: 12–21
   PubMed Web of Science ®Google Scholar
• Reid C. D. L. The significance of endogenous erythroid colonies (EEC) in haematological disorders. Blood Rev. 1987; 1: 133–140
   PubMedGoogle Scholar
• Lacombe C., Casadevall N., Varet B. Polycythaemia vera: in vitro studies of circulating erythroid progenitors. Br. J. Haematol. 1980; 44: 189–199
   PubMed Web of Science ®Google Scholar
• Yuen E., Gibson J., Rickard K. A., Kronenberg H. An analysis of peripheral blood burst forming units—erythroid in the polycythaemic states. Scand. J. Haematol. 1983; 31: 293–297
   PubMedGoogle Scholar
• Reid C. D. L., Fidler J., Kirk A. Endogenous erythroid clones (EEC) in polycythaemia and their relationship to diagnosis and the response to treatment. Br. J. Haematol. 1988; 68: 395–400
   PubMed Web of Science ®Google Scholar
• Partanen S., Juvonen E., Ikkala E., Ruutu T. Spontaneous erythroid colony formation in the differential diagnosis of erythrocytosis. Eur. J. Haematol. 1989; 42: 327–330
   PubMed Web of Science ®Google Scholar
• Biljanovic-Paunovic L., Ruvidic R., Pavlovic-Kentera V. Endogenous BFU-E in peripheral blood in diagnosis of polycythemia vera. Eur. J. Haematol. 1990; 45: 262–266
   PubMed Web of Science ®Google Scholar
• Dudley J. M., Westwood N., Leonard S., Eridani S., Pearson T. C. Primary polycythaemia: positive diagnosis using the differential response of primitive and mature erythroid progenitors to erythropoietin, interleukin 3 and alpha-interferon. Br. J. Haematol. 1990; 15: 188–194
   Web of Science ®Google Scholar
• de la Chapelle A., Träskelin A.-L, Juvonen E. Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc. Natl. Acad. Sci. 1993; 90: 4495–4499
   PubMed Web of Science ®Google Scholar
• Schwartz J., Weiss S. T. Cigarette smoking and peripheral blood leukocyte differentials. Ann. Epidemiol. 1994; 4: 236–242
   PubMedGoogle Scholar
• Whitehead T. P., Robinson D., Allaway S. L., Hale A. C. The effects of cigarette smoking and alcohol consumption on blood haemoglobin, erythrocytes and leucocytes: a dose related study on male subjects. Clin. Lab. Haem. 1995; 17: 131–138
   PubMedGoogle Scholar
• Weinreb N. J., Shih C.-F. Spurious polycythaemia. Semin. Hematol. 1975; 12: 397–407
   PubMed Web of Science ®Google Scholar
• Cotes P. M., Doré C. J., Liu Yin J. A., Lewis S. M., Messinezy M., Pearson T. C., Reid C. Determination of serum immunoreactive erythropoietin in the investigation of erythrocytosis. N. Engl. J. Med. 1986; 315: 283–287
   PubMed Web of Science ®Google Scholar
• Najean Y., Schlageter M.-H., Toubert M.-E, Podgorniak M. Radioimmunoassay of immunoreactive erythropoietin as a clinical tool for the classification of polycythaemias. Nouv. Rev. Fr. Hematol. 1990; 32: 237–240
   PubMedGoogle Scholar
• Birgegård G., Wide L. Serum erythropoietin in the diagnosis of polycythaemia and after phlebotomy treatment. Br. J. Haematol. 1992; 81: 603–606
   PubMed Web of Science ®Google Scholar
• Messinezy M., Westwood N. B., Woodcock S. P., Strong R. M., Pearson T. C. Low serum erythropoietin—a strong diagnostic criterion of primary polycythaemia even at normal haemoglobin levels. Clin. Lab. Haematol. 1995; 17: 217–220
   PubMedGoogle Scholar
• Lennert K., Nagai K., Schwarze E.-W. Patho-anatomical features of the bone marrow. Clinics in Haematology 1975; 4: 331–351
   PubMedGoogle Scholar
• Bartl R., Frisch B., Wilmanns W. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD). Eur. J. Haematol. 1993; 50: 41–52
   PubMed Web of Science ®Google Scholar
• Peterson P., Ellis J. T. The bone marrow in polycythemia vera. Polycythemia vera and the myeloproliferative disorders, L. R. Wasserman, P. D. Berk, N. I. Berlin. W. B. Saunders Company Publishers, Philadelphiapp 1995; 31–53
   Google Scholar